On July 1, the Chamber of Deputies approved the bill to guarantee coverage for health plan users of oral cancer treatments. The measure also covers radiotherapy and hemotherapy procedures and drugs to control the effects associated with reducing the impact of the treatment. Now, the initiative has been sent to the Executive Branch for its eventual enactment.
According to the text, the drugs must be delivered within 48 hours after the medical prescription and must be registered with the National Health Surveillance Agency (Anvisa in Portuguese). It also provides that the patient must be instructed on the use, conservation and eventual disposal of the drug.
Regarding the initiative, Deputy Silvia Cristina (PDT-Opposition) emphasized that this measure can be consolidated as a containment strategy for oncology patients within the framework of the provisions for reducing the movement of people to reduce the risk of contagion of COVID-19. In turn, he estimated that “the change in the legislation is fundamental for tens of thousands of Brazilians who, on a monthly basis, spend a considerable part of their budget to ensure a health plan”.
In turn, the Chamber of Deputies approved an initiative to authorize the National Executive Branch and the different sub-national levels to import drugs, supplies and equipment, as well as laboratory tests, through funding from the Pan American Health Organization (PAHO). Following the approval of the Chamber of Deputies, this bill was sent to the Senate to continue with its legislative process.